Clinical Trials Decriminalization Food 
Canna Law Blog
JANUARY 22, 2020
The company is also running a phase IIb clinical trial of its patented formulation, COMP360, which we covered in a blog post back in 2018. In that post, I explained how the Food and Drug Administration (FDA) approval process works and why this trial is so interesting and important. Denver Decriminalizes Psilocybin.
NewsMunchies
DECEMBER 13, 2021
In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. Food and Drug Administration.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
AUGUST 10, 2021
Finally, with decriminalization initiatives around psychedelics gathering momentum, it will be important not to create further disparities by deeming some psychoactive substances primarily used in white communities worthy of decriminalization, while keeping others illegal.”.
Veriheal
JUNE 29, 2021
The Right to Try Act or the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act was signed into law on May 30th, 2019, according to the US Food and Drug Administration. Just last year, the state of Oregon passed legislation decriminalizing the use of all drugs in small amounts, including psilocybin.
Cannabis Law Report
JULY 9, 2021
Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra. The state of the law on psychedelic substances is in flux. Id ; 21 CFR 312.1-10;
Cannabis Law Report
MAY 31, 2022
The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. Food and Drug Administration (FDA) approved esketamine (a component of Ketamine and sold under the brand name Spravato) for treatment-resistant depression.
Cannabis Law Report
JULY 9, 2021
federal law, despite this prohibition, a limited number of states have either sought to decriminalize or authorize the medical use of certain psychedelic drugs and substances in limited circumstances. While the medical and adult use of certain psychedelic drugs and substances are generally prohibited under U.S.
Expert insights. Personalized for you.
144 
Let's personalize your content